Antonio Ramírez de Arellano

ResearcherPublications, citations & collaboration network

Antonio Ramírez de Arellano is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 64 works, 492 citations, an h-index of 15 and an i10-index of 17.

Works

492

Citations

h-index

i10-index

IDs:OpenAlex

How has Antonio Ramírez de Arellano's publication output changed over time?

ScholarIQpublication output · 2013–2026

Output grew0% over the shown period — from 1 works in 2013 to 1 in 2026.

201320142015201620172020202120222026

What are the most-cited papers on Antonio Ramírez de Arellano?

ScholarIQmost cited works

The Economic Burden of Insulin-Related Hypoglycemia in Spain

Witesh Parekh, Nicki Hoskins, James Baker‐Knight, Antonio Ramírez de Arellano, Pedro Mezquita Raya

Diabetes Therapy. 201734 CitationsOPEN ACCESS

The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

Thomas Ward, Tray Brown, Ruth D. Lewis, Melodi Koşaner Kließ, Antonio Ramírez de Arellano, Carol Moreno Quinn

PharmacoEconomics - Open. 202232 CitationsOPEN ACCESS

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>

Phil McEwan, Piotr Ponikowski, Jason A. Davis, Giuseppe Rosano, Andrew J.S. Coats, Fabio Dorigotti, Donal O'Sullivan, Antonio Ramírez de Arellano, Ewa A. Jankowska

European Journal of Heart Failure. 202131 CitationsOPEN ACCESS

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, William J. Valentine

Diabetes Therapy. 201530 CitationsOPEN ACCESS

Self-Reported Frequency and Impact of Hypoglycemic Events in Spain

Domingo Orozco‐Beltrán, Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Manuel Galán

Diabetes Therapy. 201430 CitationsOPEN ACCESS